To investigate the efficacy of IFN-γ on HCC treatment, Kong et al. concluded that IFN-γ administration could sensitize HCC cells to ferroptosis through repressing system xc− activation via stimulating the JAK/STAT signaling pathway (Kong et al., 2021). This evidence concerns the gene SOAT1 and hepatocellular carcinoma.